National Comprehensive Cancer Network 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Dietary Glycemic Index Linked to Lung Cancer Risk in Select Populations (The University of Texas MD Anderson Cancer Center)
Consuming a diet with a high glycemic index, a classification of how rapidly carbohydrates elevate blood sugar levels, was independently associated with an increased risk of developing lung cancer in non-Hispanic whites, according to a new epidemiologic study from The University of Texas MD Anderson Cancer Center-one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 3, 2016 Category: Cancer & Oncology Source Type: news
NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma—a Rare, Yet Curable, Cancer
New patient education resources from NCCN empower patients with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma to work alongside their physicians to make informed decisions about their treatment.
FORT WASHINGTON, PA - To further educate people with Chronic Lymphocytic Leukemia (CLL) and Hodgkin Lymphoma about the most effective treatment options for their disease, the National Comprehensive Cancer Network® (NCCN®) has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ series... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 3, 2016 Category: Cancer & Oncology Source Type: news
Test Media
test test test
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 2, 2016 Category: Cancer & Oncology Source Type: news
Cancer Cells Turn Body ’s Immune System to "Dark Side" in Most Common Form of Lung Cancer (University of Colorado Cancer Center)
A University of Colorado Cancer Center study published in The Journal of Immunology shows that cancer co-opts varieties of immune system " macrophages " to promote tumor growth in the most common form of lung cancer.
University of Colorado Cancer Center is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 1, 2016 Category: Cancer & Oncology Source Type: news
Cancer Cells Turn Body’s Immune System to "Dark Side" in Most Common Form of Lung Cancer (University of Colorado Cancer Center)
A University of Colorado Cancer Center study published in The Journal of Immunology shows that cancer co-opts varieties of immune system "macrophages" to promote tumor growth in the most common form of lung cancer.
University of Colorado Cancer Center is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 1, 2016 Category: Cancer & Oncology Source Type: news
Waste in Cancer Drugs Costs $3 Billion a Year, a Study Says (
The federal Medicare program and private health insurers waste nearly $3 billion every year buying cancer medicines that are thrown out because many drug makers distribute the drugs only in vials that hold too much for most patients, a group of cancer researchers has found.
If drug makers distributed vials containing smaller quantities, nurses could pick the right volume for a patient and minimize waste. Instead, many drug makers exclusively sell one-size-fits-all vials, ensuring that many sm... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 1, 2016 Category: Cancer & Oncology Source Type: news
International Collection of Open Reading Frames Now Totals 80 Percent of Human Protein-Coding Genes, Collaboration Reports (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)
An international collaboration of organizations, including Dana-Farber Cancer Institute, has reached a milestone in creating a library of complete genetic blueprints for the thousands of different proteins in human cells. The collection - consisting of open-reading frames (ORFs), the portions of genes that code for full-length proteins - is an essential resource for scientists studying the basic mechanics of human cells and how those processes go awry in disease.
Dana-Farber/Brigham and Women... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 1, 2016 Category: Cancer & Oncology Source Type: news
New Genetic Insights into Mesothelioma (Brigham and Women ’s Hospital)
Mesothelioma is a rare but deadly form of cancer: the five-year survival rate for patients diagnosed with the disease is between five and ten percent. Although aggressive surgery can help some patients with early-stage mesothelioma, current treatments for patients with more advanced mesothelioma are not effective. Physician-researchers from the International Mesothelioma Program at Brigham and Women's Hospital (BWH) have been caring for patients with mesothelioma for the past 25 years and, in pa... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 29, 2016 Category: Cancer & Oncology Source Type: news
Is Metastatic Prostate Cancer Tailor-Made for Precision Oncology? (Fred Hutchinson Cancer Research Center)
Metastatic prostate cancer presents an appealing target for precision oncology, according to new work from scientists at Fred Hutchinson Cancer Research Center and the University of Washington. In a study published Monday in the journal Nature Medicine, the researchers showed that though metastases from different patients varied widely in their genetic characteristics, metastases within a single patient were remarkably similar. These results suggest not merely that patients with metastatic prost... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 29, 2016 Category: Cancer & Oncology Source Type: news
New Genetic Insights into Mesothelioma (Brigham and Women’s Hospital)
Mesothelioma is a rare but deadly form of cancer: the five-year survival rate for patients diagnosed with the disease is between five and ten percent. Although aggressive surgery can help some patients with early-stage mesothelioma, current treatments for patients with more advanced mesothelioma are not effective. Physician-researchers from the International Mesothelioma Program at Brigham and Women's Hospital (BWH) have been caring for patients with mesothelioma for the past 25 years and, in pa... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 29, 2016 Category: Cancer & Oncology Source Type: news
For Cancer Patients, Pain May Rise as Finances Dwindle (
This article features research from Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 29, 2016 Category: Cancer & Oncology Source Type: news
Chemo Better Option Following Pancreatic Cancer Surgery: Study (Vanderbilt-Ingram Cancer Center)
A multicenter study led by Vanderbilt University Medical Center investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.
Vanderbilt-Ingram Cancer Center is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 25, 2016 Category: Cancer & Oncology Source Type: news
Moffitt Researchers Develop a Novel Cancer Treatment Approach Based on Evolutionary Principals to Inhibit Chemo-Resistance, Prolong Progression-Free Survival (Moffitt Cancer Center)
Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse. Moffitt Cancer Center researchers hope to improve treatment outcomes with development of a novel therapeutic strategy, called adaptive therapy, which is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells.
Moffitt Cancer Center is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 24, 2016 Category: Cancer & Oncology Source Type: news
NCCN, in Collaboration with Pfizer, Awards 10 Grants for Provider Performance and Quality in Treatment of Metastatic Breast Cancer Initiatives
NCCN and Pfizer elicited proposals for the development and adoption of evidence-based initiatives to improve patient care and outcomes in metastatic breast cancer; 10 grants were awarded.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP), in collaboration with Pfizer Independent Grants for Learning & Change (IGLC), has awarded 10 grants for project proposals to develop and adopt evidence-based initiatives to improve patient care and o... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 24, 2016 Category: Cancer & Oncology Source Type: news
Juno Therapeutics, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center Announce New Immuno-Oncology Clinical Trials Unit (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)
Juno Therapeutics, Inc., a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and Fred Hutchinson Cancer Research Center have announced the creation of a new, best-in-class clinical trials unit (CTU) dedicated to immuno-oncology.
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 23, 2016 Category: Cancer & Oncology Source Type: news
